Study of Recombinant Protein Vaccine Formulations Against COVID-19 in Healthy Adults 18 Years of Age and Older
Clinical trial NCT04537208 · COMPLETED
Trial details
- NCT number
- NCT04537208
- Sponsor
- Sanofi Pasteur, a Sanofi Company
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-03
- Primary completion
- 2021-11-19
- Enrollment
- 441
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.